Hemp-derived CBD brands Charlotte’s Web and Infinite Product Co. have both been hit with proposed class action lawsuits filed in California that allege they misled consumers by marketing their products as dietary supplements when FDA has specifically...
Nestlé Health Science China has officially inaugurated its product innovation centre in Taizhou, Jiangsu province, to beef up the firm’s portfolio of Foods for Special Medical Purposes (FSMPs) in China.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
With sales of mushroom containing dietary supplements growing year-on-year by as much as 40%, and food and beverage companies getting in on the act, demand for the fungi has been “unreal”, says Jeff Chilton, President of Nammex Organic Mushroom Extracts.
The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.
A Consumer Reports article detailing what it calls quality failures in turmeric and echinacea supplements has been assailed as being based on false assumptions and arbitrary parameters.
Pharmactive Biotech Products, S.L., the clean-label saffron extract maker, says it has optimised product quality and concentration with AFF ON Cool-Tech.
The 20th annual Oxford International Conference on the Science of Botanicals is now accepting abstract submissions. The event is held March 30th - April 2nd, 2020 in Oxford, Mississippi.
A new poll shows many consumers would stop using CBD products if they knew FDA has not yet set regulations around them. The poll was commissioned by the Natural Products Association.
New Trump Administration executive orders on guidance documents from regulatory agencies likely will affect the dietary supplement industry, an attorney says.
Early data on the Food Safety Modernization Act suggests the new law is working as compliance is improving and recalls have hit a five year low. A newly launched web portal will help track that data.
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
The United Natural Products Alliance has signed a Memorandum of Understanding (MOU) with the University of Arkansas for Medical Sciences, allowing industry stakeholders access to the medical school’s analytical, technical and policy expertise.
